ID   IHH_HUMAN               Reviewed;         411 AA.
AC   Q14623; B9EGM5; O43322; Q8N4B9;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   19-JUL-2003, sequence version 4.
DT   22-JUL-2015, entry version 167.
DE   RecName: Full=Indian hedgehog protein;
DE            Short=IHH;
DE   AltName: Full=HHG-2;
DE   Contains:
DE     RecName: Full=Indian hedgehog protein N-product;
DE   Contains:
DE     RecName: Full=Indian hedgehog protein C-product;
DE   Flags: Precursor;
GN   Name=IHH;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Tate G., Kishimoto K., Mitsuya T.;
RT   "Expression of Sonic hedgehog and its receptor Patched/Smoothened in
RT   human cancer cell lines and embryonic organs.";
RL   J. Biochem. Mol. Biol. Biophys. 4:27-34(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 100-411.
RC   TISSUE=Fetal lung;
RX   PubMed=7590746; DOI=10.1006/geno.1995.1104;
RA   Marigo V., Roberts D.J., Lee S.M.K., Tsukurov O., Levi T.,
RA   Gastier J.M., Epstein D.J., Gilbert D.J., Copeland N.G., Seidman C.E.,
RA   Jenkins N.A., Seidman J.G., McMahon A.P., Tabin C.;
RT   "Cloning, expression, and chromosomal location of SHH and IHH: two
RT   human homologues of the Drosophila segment polarity gene hedgehog.";
RL   Genomics 28:44-51(1995).
RN   [5]
RP   NUCLEOTIDE SEQUENCE OF 124-172.
RX   PubMed=7720571;
RA   Chang D.T., Lopez A., von Kessler D.P., Chiang C., Simandl B.K.,
RA   Zhao R., Seldin M.F., Fallon J.F., Beachy P.A.;
RT   "Products, genetic linkage and limb patterning activity of a murine
RT   hedgehog gene.";
RL   Development 120:3339-3353(1994).
RN   [6]
RP   PALMITOYLATION AT CYS-28.
RX   PubMed=9593755; DOI=10.1074/jbc.273.22.14037;
RA   Pepinsky R.B., Zeng C., Wen D., Rayhorn P., Baker D.P., Williams K.P.,
RA   Bixler S.A., Ambrose C.M., Garber E.A., Miatkowski K., Taylor F.R.,
RA   Wang E.A., Galdes A.;
RT   "Identification of a palmitic acid-modified form of human Sonic
RT   hedgehog.";
RL   J. Biol. Chem. 273:14037-14045(1998).
RN   [7]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-282.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,
RA   Moore R.J., Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 29-193 IN COMPLEXES WITH
RP   CALCIUM IONS; ZINC IONS; BOC AND CDON, DOMAIN, AND INTERACTION WITH
RP   BOC AND CDON.
RX   PubMed=20519495; DOI=10.1074/jbc.M110.131680;
RA   Kavran J.M., Ward M.D., Oladosu O.O., Mulepati S., Leahy D.J.;
RT   "All mammalian Hedgehog proteins interact with cell adhesion molecule,
RT   down-regulated by oncogenes (CDO) and brother of CDO (BOC) in a
RT   conserved manner.";
RL   J. Biol. Chem. 285:24584-24590(2010).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (1.44 ANGSTROMS) OF 28-202 OF WILD TYPE AND
RP   VARIANTS BDA1 LYS-95; GLU-100 AND LYS-131 IN COMPLEX WITH ZINC IONS,
RP   FUNCTION, SUBUNIT, INTERACTION WITH PTCH1, SUBCELLULAR LOCATION,
RP   CHOLESTERYLATION, PALMITOYLATION, MUTAGENESIS OF GLU-95, DOMAIN, AND
RP   CHARACTERIZATION OF VARIANTS BDA1 LYS-95; ASN-100; GLU-100 AND
RP   LYS-131.
RX   PubMed=21537345; DOI=10.1038/cr.2011.76;
RA   Ma G., Yu J., Xiao Y., Chan D., Gao B., Hu J., He Y., Guo S., Zhou J.,
RA   Zhang L., Gao L., Zhang W., Kang Y., Cheah K.S., Feng G., Guo X.,
RA   Wang Y., Zhou C.Z., He L.;
RT   "Indian hedgehog mutations causing brachydactyly type A1 impair
RT   Hedgehog signal transduction at multiple levels.";
RL   Cell Res. 21:1343-1357(2011).
RN   [10]
RP   VARIANTS BDA1 LYS-95; GLU-100 AND LYS-131.
RX   PubMed=11455389; DOI=10.1038/ng577;
RA   Gao B., Guo J., She C., Shu A., Yang M., Tan Z., Yang X., Guo S.,
RA   Feng G., He L.;
RT   "Mutations in IHH, encoding Indian hedgehog, cause brachydactyly type
RT   A-1.";
RL   Nat. Genet. 28:386-388(2001).
RN   [11]
RP   VARIANT BDA1 ASN-100.
RX   PubMed=12384778; DOI=10.1007/s00439-002-0815-2;
RA   McCready M.E., Sweeney E., Fryer A.E., Donnai D., Baig A., Racacho L.,
RA   Warman M.L., Hunter A.G.W., Bulman D.E.;
RT   "A novel mutation in the IHH gene causes brachydactyly type A1: a 95-
RT   year-old mystery resolved.";
RL   Hum. Genet. 111:368-375(2002).
RN   [12]
RP   VARIANTS ACFD LEU-46 AND ALA-190.
RX   PubMed=12632327; DOI=10.1086/374318;
RA   Hellemans J., Coucke P.J., Giedion A., De Paepe A., Kramer P.,
RA   Beemer F., Mortier G.R.;
RT   "Homozygous mutations in IHH cause acrocapitofemoral dysplasia, an
RT   autosomal recessive disorder with cone-shaped epiphyses in hands and
RT   hips.";
RL   Am. J. Hum. Genet. 72:1040-1046(2003).
CC   -!- FUNCTION: Intercellular signal essential for a variety of
CC       patterning events during development. Binds to the patched (PTC)
CC       receptor, which functions in association with smoothened (SMO), to
CC       activate the transcription of target genes. Implicated in
CC       endochondral ossification: may regulate the balance between growth
CC       and ossification of the developing bones. Induces the expression
CC       of parathyroid hormone-related protein (PTHRP) (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Homooligomer (indian hedgehog protein N-product).
CC       Interacts with BOC and CDON. Interacts with PTCH1.
CC       {ECO:0000269|PubMed:20519495, ECO:0000269|PubMed:21537345}.
CC   -!- SUBCELLULAR LOCATION: Indian hedgehog protein N-product: Cell
CC       membrane {ECO:0000250}; Lipid-anchor {ECO:0000250}; Extracellular
CC       side {ECO:0000250}. Note=The N-terminal peptide remains associated
CC       with the cell surface. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Indian hedgehog protein C-product: Secreted,
CC       extracellular space {ECO:0000250}. Note=The C-terminal peptide
CC       diffuses from the cell. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:21537345}.
CC   -!- TISSUE SPECIFICITY: Expressed in embryonic lung, and in adult
CC       kidney and liver.
CC   -!- DOMAIN: The indian hedgehog protein N-product binds calcium and
CC       zinc ions; this stabilizes the protein fold and is essential for
CC       protein-protein interactions mediated by this domain.
CC       {ECO:0000269|PubMed:20519495, ECO:0000269|PubMed:21537345}.
CC   -!- PTM: The C-terminal domain displays an autoproteolysis activity
CC       and a cholesterol transferase activity. Both activities result in
CC       the cleavage of the full-length protein and covalent attachment of
CC       a cholesterol moiety to the C-terminal of the newly generated N-
CC       terminal fragment (N-product). The N-product is the active species
CC       in both local and long-range signaling, whereas the C-product has
CC       no signaling activity (By similarity). {ECO:0000250}.
CC   -!- PTM: Cholesterylation is required for N-product targeting to lipid
CC       rafts and multimerization. {ECO:0000269|PubMed:21537345}.
CC   -!- PTM: Palmitoylated. N-palmitoylation is required for N-product
CC       multimerization and full activity. {ECO:0000269|PubMed:21537345,
CC       ECO:0000269|PubMed:9593755}.
CC   -!- DISEASE: Brachydactyly A1 (BDA1) [MIM:112500]: A form of
CC       brachydactyly. Brachydactyly defines a group of inherited
CC       malformations characterized by shortening of the digits due to
CC       abnormal development of the phalanges and/or the metacarpals.
CC       Brachydactyly type A1 is characterized by middle phalanges of all
CC       the digits rudimentary or fused with the terminal phalanges. The
CC       proximal phalanges of the thumbs and big toes are short.
CC       {ECO:0000269|PubMed:11455389, ECO:0000269|PubMed:12384778}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Acrocapitofemoral dysplasia (ACFD) [MIM:607778]: A
CC       disorder characterized by short stature of variable severity with
CC       postnatal onset. The most constant radiographic abnormalities are
CC       observed in the tubular bones of the hands and in the proximal
CC       part of the femur. Cone-shaped epiphyses or a similar epiphyseal
CC       configuration with premature epimetaphyseal fusion result in
CC       shortening of the skeletal components involved. Cone-shaped
CC       epiphyses are also present to a variable extent at the shoulders,
CC       knees and ankles. {ECO:0000269|PubMed:12632327}. Note=The disease
CC       is caused by mutations affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the hedgehog family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB018076; BAA33523.2; -; Genomic_DNA.
DR   EMBL; CH471063; EAW70675.1; -; Genomic_DNA.
DR   EMBL; BC034757; AAH34757.2; -; mRNA.
DR   EMBL; BC136587; AAI36588.1; -; mRNA.
DR   EMBL; BC136588; AAI36589.1; -; mRNA.
DR   EMBL; L38517; AAA62178.1; -; mRNA.
DR   CCDS; CCDS33380.1; -.
DR   RefSeq; NP_002172.2; NM_002181.3.
DR   UniGene; Hs.654504; -.
DR   PDB; 3K7G; X-ray; 1.50 A; B=28-202.
DR   PDB; 3K7H; X-ray; 1.50 A; B=28-202.
DR   PDB; 3K7I; X-ray; 1.44 A; B=28-202.
DR   PDB; 3K7J; X-ray; 1.90 A; B=28-202.
DR   PDB; 3N1F; X-ray; 1.60 A; A/B=29-193.
DR   PDB; 3N1M; X-ray; 1.69 A; B=29-193.
DR   PDB; 3N1O; X-ray; 2.55 A; A/B/C=29-193.
DR   PDB; 3N1P; X-ray; 2.70 A; B=29-193.
DR   PDBsum; 3K7G; -.
DR   PDBsum; 3K7H; -.
DR   PDBsum; 3K7I; -.
DR   PDBsum; 3K7J; -.
DR   PDBsum; 3N1F; -.
DR   PDBsum; 3N1M; -.
DR   PDBsum; 3N1O; -.
DR   PDBsum; 3N1P; -.
DR   ProteinModelPortal; Q14623; -.
DR   SMR; Q14623; 41-197, 203-349.
DR   BioGrid; 109765; 1.
DR   IntAct; Q14623; 1.
DR   STRING; 9606.ENSP00000295731; -.
DR   MEROPS; C46.003; -.
DR   BioMuta; IHH; -.
DR   DMDM; 33112634; -.
DR   MaxQB; Q14623; -.
DR   PaxDb; Q14623; -.
DR   PeptideAtlas; Q14623; -.
DR   PRIDE; Q14623; -.
DR   Ensembl; ENST00000295731; ENSP00000295731; ENSG00000163501.
DR   GeneID; 3549; -.
DR   KEGG; hsa:3549; -.
DR   UCSC; uc002vjo.2; human.
DR   CTD; 3549; -.
DR   GeneCards; GC02M219919; -.
DR   H-InvDB; HIX0023995; -.
DR   HGNC; HGNC:5956; IHH.
DR   HPA; CAB009211; -.
DR   MIM; 112500; phenotype.
DR   MIM; 600726; gene.
DR   MIM; 607778; phenotype.
DR   neXtProt; NX_Q14623; -.
DR   Orphanet; 63446; Acrocapitofemoral dysplasia.
DR   Orphanet; 93388; Brachydactyly type A1.
DR   PharmGKB; PA29769; -.
DR   eggNOG; NOG250647; -.
DR   GeneTree; ENSGT00390000001117; -.
DR   HOGENOM; HOG000233428; -.
DR   HOVERGEN; HBG005480; -.
DR   InParanoid; Q14623; -.
DR   KO; K11989; -.
DR   OMA; LGEGVHW; -.
DR   OrthoDB; EOG779NZ5; -.
DR   PhylomeDB; Q14623; -.
DR   TreeFam; TF106458; -.
DR   Reactome; REACT_18372; Class B/2 (Secretin family receptors).
DR   Reactome; REACT_264256; Release of Hh-Np from the secreting cell.
DR   Reactome; REACT_264605; Hedgehog ligand biogenesis.
DR   Reactome; REACT_268573; Ligand-receptor interactions.
DR   SignaLink; Q14623; -.
DR   EvolutionaryTrace; Q14623; -.
DR   GeneWiki; IHH_(protein); -.
DR   GenomeRNAi; 3549; -.
DR   NextBio; 13856; -.
DR   PRO; PR:Q14623; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; Q14623; -.
DR   CleanEx; HS_IHH; -.
DR   Genevisible; Q14623; HS.
DR   GO; GO:0005615; C:extracellular space; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005578; C:proteinaceous extracellular matrix; IEA:Ensembl.
DR   GO; GO:0005509; F:calcium ion binding; IDA:UniProtKB.
DR   GO; GO:0005113; F:patched binding; IPI:UniProtKB.
DR   GO; GO:0008233; F:peptidase activity; IEA:UniProtKB-KW.
DR   GO; GO:0045453; P:bone resorption; IEA:Ensembl.
DR   GO; GO:0060220; P:camera-type eye photoreceptor cell fate commitment; IEA:Ensembl.
DR   GO; GO:0051216; P:cartilage development; IMP:AgBase.
DR   GO; GO:0001708; P:cell fate specification; IEA:Ensembl.
DR   GO; GO:0048469; P:cell maturation; IEA:Ensembl.
DR   GO; GO:0007267; P:cell-cell signaling; IEA:InterPro.
DR   GO; GO:0035988; P:chondrocyte proliferation; IEA:Ensembl.
DR   GO; GO:0048596; P:embryonic camera-type eye morphogenesis; IEA:Ensembl.
DR   GO; GO:0048557; P:embryonic digestive tract morphogenesis; IEA:Ensembl.
DR   GO; GO:0042733; P:embryonic digit morphogenesis; IMP:AgBase.
DR   GO; GO:0009880; P:embryonic pattern specification; IEA:Ensembl.
DR   GO; GO:0072498; P:embryonic skeletal joint development; IEA:Ensembl.
DR   GO; GO:0003382; P:epithelial cell morphogenesis; IEA:Ensembl.
DR   GO; GO:0090136; P:epithelial cell-cell adhesion; IEA:Ensembl.
DR   GO; GO:0060323; P:head morphogenesis; IEA:Ensembl.
DR   GO; GO:0001947; P:heart looping; ISS:BHF-UCL.
DR   GO; GO:0001701; P:in utero embryonic development; IEA:Ensembl.
DR   GO; GO:0016539; P:intein-mediated protein splicing; IEA:InterPro.
DR   GO; GO:0060135; P:maternal process involved in female pregnancy; IEA:Ensembl.
DR   GO; GO:0035264; P:multicellular organism growth; IEA:Ensembl.
DR   GO; GO:0046639; P:negative regulation of alpha-beta T cell differentiation; ISS:BHF-UCL.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl.
DR   GO; GO:0048074; P:negative regulation of eye pigmentation; IEA:Ensembl.
DR   GO; GO:0033088; P:negative regulation of immature T cell proliferation in thymus; ISS:BHF-UCL.
DR   GO; GO:0009968; P:negative regulation of signal transduction; IEA:Ensembl.
DR   GO; GO:0033085; P:negative regulation of T cell differentiation in thymus; ISS:BHF-UCL.
DR   GO; GO:0048666; P:neuron development; IEA:Ensembl.
DR   GO; GO:0001649; P:osteoblast differentiation; IEA:Ensembl.
DR   GO; GO:0031016; P:pancreas development; IEA:Ensembl.
DR   GO; GO:0001569; P:patterning of blood vessels; IEA:Ensembl.
DR   GO; GO:0046638; P:positive regulation of alpha-beta T cell differentiation; ISS:BHF-UCL.
DR   GO; GO:0032332; P:positive regulation of chondrocyte differentiation; IEA:Ensembl.
DR   GO; GO:0032967; P:positive regulation of collagen biosynthetic process; IEA:Ensembl.
DR   GO; GO:0050679; P:positive regulation of epithelial cell proliferation; IEA:Ensembl.
DR   GO; GO:0002053; P:positive regulation of mesenchymal cell proliferation; IEA:Ensembl.
DR   GO; GO:0045880; P:positive regulation of smoothened signaling pathway; ISS:BHF-UCL.
DR   GO; GO:0033089; P:positive regulation of T cell differentiation in thymus; ISS:BHF-UCL.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl.
DR   GO; GO:0006029; P:proteoglycan metabolic process; IEA:Ensembl.
DR   GO; GO:0040008; P:regulation of growth; IEA:Ensembl.
DR   GO; GO:0032355; P:response to estradiol; IEA:Ensembl.
DR   GO; GO:0003406; P:retinal pigment epithelium development; IEA:Ensembl.
DR   GO; GO:0001501; P:skeletal system development; IMP:UniProtKB.
DR   GO; GO:0048745; P:smooth muscle tissue development; IEA:Ensembl.
DR   GO; GO:0007224; P:smoothened signaling pathway; IDA:UniProtKB.
DR   GO; GO:0061053; P:somite development; ISS:BHF-UCL.
DR   GO; GO:0030704; P:vitelline membrane formation; IEA:Ensembl.
DR   Gene3D; 2.170.16.10; -; 1.
DR   Gene3D; 3.30.1380.10; -; 1.
DR   InterPro; IPR001657; Hedgehog.
DR   InterPro; IPR028992; Hedgehog/Intein_dom.
DR   InterPro; IPR009045; Hedgehog_sig/DD-Pept_Zn-bd_dom.
DR   InterPro; IPR000320; Hedgehog_signalling_dom.
DR   InterPro; IPR001767; Hint_dom.
DR   InterPro; IPR003586; Hint_dom_C.
DR   InterPro; IPR003587; Hint_dom_N.
DR   InterPro; IPR006141; Intein_N.
DR   Pfam; PF01085; HH_signal; 1.
DR   Pfam; PF01079; Hint; 1.
DR   PIRSF; PIRSF009400; Peptidase_C46; 1.
DR   PRINTS; PR00632; SONICHHOG.
DR   SMART; SM00305; HintC; 1.
DR   SMART; SM00306; HintN; 1.
DR   SUPFAM; SSF51294; SSF51294; 1.
DR   SUPFAM; SSF55166; SSF55166; 1.
DR   PROSITE; PS50817; INTEIN_N_TER; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Autocatalytic cleavage; Calcium; Cell membrane;
KW   Complete proteome; Developmental protein; Disease mutation;
KW   Glycoprotein; Hydrolase; Lipoprotein; Membrane; Metal-binding;
KW   Palmitate; Protease; Reference proteome; Secreted; Signal; Zinc.
FT   SIGNAL        1     27       {ECO:0000305}.
FT   CHAIN        28    411       Indian hedgehog protein.
FT                                /FTId=PRO_0000013229.
FT   CHAIN        28    202       Indian hedgehog protein N-product.
FT                                /FTId=PRO_0000013230.
FT   CHAIN       203    411       Indian hedgehog protein C-product.
FT                                /FTId=PRO_0000013231.
FT   METAL        94     94       Calcium 1.
FT   METAL        95     95       Calcium 1.
FT   METAL        95     95       Calcium 2.
FT   METAL       100    100       Calcium 1.
FT   METAL       130    130       Calcium 1; via carbonyl oxygen.
FT   METAL       131    131       Calcium 1.
FT   METAL       131    131       Calcium 2.
FT   METAL       134    134       Calcium 2.
FT   METAL       136    136       Calcium 2.
FT   METAL       145    145       Zinc.
FT   METAL       152    152       Zinc.
FT   METAL       187    187       Zinc.
FT   SITE        202    203       Cleavage; by autolysis. {ECO:0000250}.
FT   SITE        248    248       Involved in cholesterol transfer.
FT                                {ECO:0000250}.
FT   SITE        272    272       Involved in auto-cleavage. {ECO:0000250}.
FT   SITE        275    275       Essential for auto-cleavage.
FT                                {ECO:0000250}.
FT   LIPID        28     28       N-palmitoyl cysteine.
FT                                {ECO:0000305|PubMed:9593755}.
FT   LIPID       202    202       Cholesterol glycine ester. {ECO:0000250}.
FT   CARBOHYD    282    282       N-linked (GlcNAc...).
FT                                {ECO:0000269|PubMed:16335952}.
FT   VARIANT      46     46       P -> L (in ACFD).
FT                                {ECO:0000269|PubMed:12632327}.
FT                                /FTId=VAR_015981.
FT   VARIANT      95     95       E -> K (in BDA1; decreases the stability
FT                                of the indian hedgehog protein N-
FT                                product). {ECO:0000269|PubMed:11455389,
FT                                ECO:0000269|PubMed:21537345}.
FT                                /FTId=VAR_015982.
FT   VARIANT     100    100       D -> E (in BDA1; decreases the stability
FT                                of the indian hedgehog protein N-
FT                                product). {ECO:0000269|PubMed:11455389,
FT                                ECO:0000269|PubMed:21537345}.
FT                                /FTId=VAR_015983.
FT   VARIANT     100    100       D -> N (in BDA1; decreases the stability
FT                                of the indian hedgehog protein N-product;
FT                                dbSNP:rs28936377).
FT                                {ECO:0000269|PubMed:12384778,
FT                                ECO:0000269|PubMed:21537345}.
FT                                /FTId=VAR_015984.
FT   VARIANT     131    131       E -> K (in BDA1; no effect on the
FT                                stability of the indian hedgehog protein
FT                                N-product). {ECO:0000269|PubMed:11455389,
FT                                ECO:0000269|PubMed:21537345}.
FT                                /FTId=VAR_015985.
FT   VARIANT     190    190       V -> A (in ACFD).
FT                                {ECO:0000269|PubMed:12632327}.
FT                                /FTId=VAR_015986.
FT   MUTAGEN      95     95       E->G: Increases the lysosomal degradation
FT                                of the indian hedgehog protein N-product.
FT                                {ECO:0000269|PubMed:21537345}.
FT   CONFLICT    100    100       D -> R (in Ref. 4; AAA62178).
FT                                {ECO:0000305}.
FT   CONFLICT    246    246       F -> L (in Ref. 1; BAA33523).
FT                                {ECO:0000305}.
FT   CONFLICT    309    309       V -> A (in Ref. 1; BAA33523).
FT                                {ECO:0000305}.
FT   STRAND       52     56       {ECO:0000244|PDB:3K7I}.
FT   TURN         61     64       {ECO:0000244|PDB:3K7I}.
FT   STRAND       73     75       {ECO:0000244|PDB:3N1P}.
FT   HELIX        76     80       {ECO:0000244|PDB:3K7I}.
FT   STRAND       89     91       {ECO:0000244|PDB:3K7I}.
FT   STRAND       96     98       {ECO:0000244|PDB:3K7I}.
FT   HELIX        99    101       {ECO:0000244|PDB:3K7I}.
FT   HELIX       105    121       {ECO:0000244|PDB:3K7I}.
FT   STRAND      127    131       {ECO:0000244|PDB:3K7I}.
FT   HELIX       144    147       {ECO:0000244|PDB:3K7I}.
FT   STRAND      150    155       {ECO:0000244|PDB:3K7I}.
FT   HELIX       160    162       {ECO:0000244|PDB:3K7I}.
FT   HELIX       163    172       {ECO:0000244|PDB:3K7I}.
FT   STRAND      176    182       {ECO:0000244|PDB:3K7I}.
FT   STRAND      185    189       {ECO:0000244|PDB:3K7I}.
FT   STRAND      193    195       {ECO:0000244|PDB:3K7I}.
SQ   SEQUENCE   411 AA;  45251 MW;  4DA90C83F5ABF758 CRC64;
     MSPARLRPRL HFCLVLLLLL VVPAAWGCGP GRVVGSRRRP PRKLVPLAYK QFSPNVPEKT
     LGASGRYEGK IARSSERFKE LTPNYNPDII FKDEENTGAD RLMTQRCKDR LNSLAISVMN
     QWPGVKLRVT EGWDEDGHHS EESLHYEGRA VDITTSDRDR NKYGLLARLA VEAGFDWVYY
     ESKAHVHCSV KSEHSAAAKT GGCFPAGAQV RLESGARVAL SAVRPGDRVL AMGEDGSPTF
     SDVLIFLDRE PHRLRAFQVI ETQDPPRRLA LTPAHLLFTA DNHTEPAARF RATFASHVQP
     GQYVLVAGVP GLQPARVAAV STHVALGAYA PLTKHGTLVV EDVVASCFAA VADHHLAQLA
     FWPLRLFHSL AWGSWTPGEG VHWYPQLLYR LGRLLLEEGS FHPLGMSGAG S
//
